The Arora Report

Rss Facebook Twitter Linkedin

IMGN

IMMUNOGEN (IMGN): WHAT TO DO NOW

ImmunoGen (IMGN )  stock has moved up sharply on the news that T-DM1  produced by ImmunoGen improved survival in patients suffering from HER2-Positive  Metastatic Breast Cancer. T-DM1  contains DM1  cancer cell killing agent produced by ImmunoGen attached to an HER-2 targeting antibody. This development is mostly already in the stock

Read More
September 26, 2011

9 Winners. 9 Losers. Gold, Silver & AI Trade Zones.

9 Winners. 9 Losers.
Gold, Silver & AI Trade Zones.

A new market cycle is forming.

AI, Metals &
Memory Playbook

See where sophisticated investors are positioning across software, precious metals, and AI memory.

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

Skip to content